A0011 PSMA-RLT vs. cabazitaxel for Japanese metastatic castration resistance prostate cancer: Comparison of oncological outcomes using propensity score matching

European Urology 2026

View at publisher
Authors: Y. Enei, T. Yanagisawa, H. Kuruma, Chieko Okazaki, A. Okada, K. Watanabe, Nat P. Lenzo, T. Kimura, K. Miki
DOI: 10.1016/s0302-2838(26)00079-5
Cited by: 0

Fields of Study & Subjects

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Radiopharmaceutical Chemistry and Applications

Publication details

Journal / source
European Urology
Volume
89
Pages
S1–S2
Publication date
13 February 2026
Language
EN